Home / Resources / Test Your Knowledge / GLP-1 Receptor Agonists vs Mealtime Insulin

GLP-1 Receptor Agonists vs Mealtime Insulin

Apr 8, 2017

Which one of the following is an advantage of a glucagon-like peptide-1 (GLP-1) receptor agonist over mealtime insulin?


Correct Answer is D. All of the above

Explanation: GLP-1 receptor agonists are a strong competitor to mealtime insulin because they offer similar efficacy with fewer adverse effects. They typically have glucose-dependent insulin secretion and are associated with less hypoglycemia. They often require fewer injections, usually 1 or 2 per day, instead of at every meal. They are associated with less weight gain.

Reference: Prasad-Reddy L, Isaacs D. Drugs Context. 2015;4:212283.